Top Markets
Coin of the day
Rekah Pharmaceutical Industry Ltd. Rekah Pharmaceutical Industry Ltd.

Rekah Pharmaceutical Industry Ltd.

REKA
Rank in Stocks #39666
Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in... Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in Holon, Israel, specializes in the production, marketing, distribution, and sale of a broad spectrum of healthcare items across Israel. The company's offerings include both prescription and over-the-counter medicines, dermo-cosmetic products, vitamins, and nutritional supplements. Its extensive portfolio comprises approximately 280 distinct pharmaceutical drugs used in various medical sectors. These encompass steroid tablets, antibiotics (such as penicillin and cephalosporin), eye drops and ointments for allergies, infections, and dryness, baby products, and dermatological treatments.
Share Price
$3.45
Last synced: 2026-08-13
Market Cap
$394.03K
Change (1 day)
0.00%
Change (1 year)
-2.96%
Country
IL
Trade Rekah Pharmaceutical Industry Ltd. (REKA)

Category

P/E ratio for Rekah Pharmaceutical Industry Ltd. (REKA)
P/E ratio as of 2026 TTM: 0
According to Rekah Pharmaceutical Industry Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Rekah Pharmaceutical Industry Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.